✦ LIBER ✦

Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor

✍ Scribed by Weiland, Gregory A.; Minneman, Kenneth P.; Molinoff, Perry B.

Book ID: 109716084
Publisher: Nature Publishing Group
Year: 1979
Tongue: English
Weight: 435 KB
Volume: 281
Category: Article
ISSN: 0028-0836
DOI: 10.1038/281114a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A model of the adrenergic β2 receptor an

A model of the adrenergic β2 receptor and binding sites for agonist and antagonist

✍ X.Q. Lewell 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Interactions between an α2-adrenergic an

Interactions between an α2-adrenergic antagonist and a β3-adrenergic agonist on the expression of UCP2 and UCP3 in rats

✍ J. Gómez-Ambrosi; G. Frühbeck; J. A. Martínez 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 795 KB

Interaction of Oxytocin and Vasopressin

Interaction of Oxytocin and Vasopressin with β-Adrenergic Receptors in the Kidney

✍ POISNER, A. M. 📂 Article 📅 1964 🏛 Nature Publishing Group 🌐 English ⚖ 258 KB

Insights into the binding modes of human

Insights into the binding modes of human β3-adrenergic receptor agonists with ligand-based and receptor-based methods

✍ Fangfang Jin; Chunhua Lu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 1001 KB

The Influence of β-Adrenergic Agonists a

The Influence of β-Adrenergic Agonists and Antagonists on T-Wave Alternans in Patients with and Without Ventricular Tachyarrhythmia

✍ NORIHIRO KOMIYA; SINJI SETO; KOJIRO NAKAO; KATSUSUKE YANO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Different ligands–different receptor con

Different ligands–different receptor conformations: Modeling of the hERα LBD in complex with agonists and antagonists

✍ Ursula Egner; Nikolaus Heinrich; Marc Ruff; Monique Gangloff; Anke Mueller-Fahrn 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

## Abstract The aim of this study is to compare crystal structures of nuclear receptor ligand binding domains in complex with different agonists and partial agonists to achieve a better understanding of the three‐dimensional structures and their ligand‐induced conformational changes. This led to th